title: The Impact of Disease Modification on the Cost-Effectiveness of Pegloticase for the Treatment of Severe Debilitating Chronic Tophaceous Gout In Adult Patients.
authors.affiliation: Access Partnership, Horsham, PA, USA.
authors.forename: K
authors.initials: K
authors.lastname: Wallerstein
authors.affiliation: Tolley Health Economics Ltd., Buxton, Derbyshire, UK.
authors.forename: K
authors.initials: K
authors.lastname: Tolley
authors.affiliation: Vegter Health Economic Research, Amersfoort, The Netherlands.
authors.forename: S
authors.initials: S
authors.lastname: Vegter